Human heart structure beats 21 days in pig embryo
The study, led by Lai Liangxue's team from the Guangzhou Institutes of Biomedicine and Health under the Chinese Academy of Sciences, was announced at the International Society for Stem Cell Research's annual meeting in Hong Kong on June 12.
Previously, the team had cultivated human kidneys in pigs for up to 28 days.
According to a report in Nature on June 13, the team reprogrammed human stem cells by introducing genes to prevent cell death and improve their survival in pigs.
At the early blastocyst stage - early in pregnancy when a ball of cells forms - they implanted pre-modified human stem cells into pig embryos, which were then transferred to surrogate sows.
Researchers observed embryonic hearts growing to a human-equivalent size, comparable to a fingertip, at the same developmental stage - and still beating, according to the Nature report.
Using prelabelled luminescent biomarkers, the researchers reported detecting light from human cells coinciding with an embryonic heartbeat.
Nature quoted Lai as saying that modified embryos developed typically sized beating hearts, but the report did not say what proportion of the hearts were human cells.
The embryos survived only 21 days. Lai suggested at the meeting, "human cells may disrupt pig heart function".
In September 2023, Lai's team generated early human kidneys in pig embryos with 70 per cent human cells, in a study featured as a cover story in Cell Stem Cell.
Their technology could revolutionise organ transplants. However, clinical applications may take years to develop.
At the same conference, a research team led by Shen Xiling from the University of Texas MD Anderson Cancer Centre announced it had integrated human cells into mouse embryo intestines, livers and even brains.
Unlike the technical approach used by Lai's team, the Anderson Cancer Centre team first reprogrammed human stem cells and directly cultivated organoids - or miniature versions of organs grown from stem cells - of the intestine, liver and brain in culture dishes.
One month post-birth, around 10% of mice had human intestinal cells; incorporation into the liver and brain was lower.
Transplants treat organ failure, but accessibility is limited by a shortage of donor organs.
Pigs are suitable donors because they have anatomical similarities to humans, but immune responses that cause human rejection prevent their direct use. Growing human organs in pigs offers a potential solution.
This research direction is known as human-animal chimeras, referring to the combination of human and animal cells or tissues within a single organism. However, research on human-animal chimeras has sparked ethical controversies.
China introduced regulations last year, stating that human cell transplants into non-human animals for research purposes could only be conducted when other methods could not resolve the research issues.
At the conference, Stanford University's Hiromitsu Nakauchi urged further analysis to confirm human origin of the cells in the pig embryo experiment, noting that the localisation of fluorescent cells in the heart made integration with pig cells unclear.
Hideki Masaki of the Institute of Science Tokyo added: "For transplantable hearts, organs must be exclusively human to prevent immune rejection."
On June 16, Nature
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bangkok Post
07-08-2025
- Bangkok Post
Dangerous dreams: Inside internet's 'sleepmaxxing' craze
WASHINGTON - From mouth taping to rope-assisted neck swinging, a viral social media trend is promoting extreme bedtime routines that claim to deliver perfect sleep -- despite scant medical evidence and potential safety risks. Influencers on platforms including TikTok and X are fuelling a growing wellness obsession popularly known as "sleepmaxxing," a catch-all term for activities and products aimed at optimising sleep quality. The explosive rise of the trend -- generating tens of millions of posts -- underscores social media's power to legitimise unproven health practices, particularly as tech platforms scale back content moderation. One so-called insomnia cure involves people hanging by their necks with ropes or belts and swinging their bodies in the air. "Those who try it claim their sleep problems have significantly improved," said one clip on X that racked up more than 11 million views. Experts have raised alarm about the trick, following a Chinese state broadcaster's report that attributed at least one fatality in China last year to a similar "neck hanging" routine. Such sleepmaxxing techniques are "ridiculous, potentially harmful, and evidence-free," Timothy Caulfield, a misinformation expert from the University of Alberta in Canada, told AFP. "It is a good example of how social media can normalize the absurd." Another popular practice is taping of the mouth for sleep, promoted as a way to encourage nasal breathing. Influencers claim it offers broad benefits, from better sleep and improved oral health to reduced snoring. But a report from George Washington University found that most of these claims were not supported by medical research. Experts have also warned the practice could be dangerous, particularly for those suffering from sleep apnea, a condition that disrupts breathing during sleep. Other unfounded tricks touted by sleepmaxxing influencers include wearing blue- or red-tinted glasses, using weighted blankets, and eating two kiwis just before bed. ' Damaging' "My concern with the 'sleepmaxxing' trend -- particularly as it's presented on platforms like TikTok -- is that much of the advice being shared can be actively unhelpful, even damaging, for people struggling with real sleep issues," Kathryn Pinkham, a Britain-based insomnia specialist, told AFP. "While some of these tips might be harmless for people who generally sleep well, they can increase pressure and anxiety for those dealing with chronic insomnia or other persistent sleep problems." While sound and sufficient sleep is considered a cornerstone of good health, experts warn that the trend may be contributing to orthosomnia, an obsessive preoccupation with achieving perfect sleep. "The pressure to get perfect sleep is embedded in the sleepmaxxing culture," said Eric Zhou of Harvard Medical School. "While prioritising restful sleep is commendable, setting perfection as your goal is problematic. Even good sleepers vary from night to night." Pinkham added that poor sleep was often fuelled by the "anxiety to fix it," a fact largely unacknowledged by sleepmaxxing influencers. "The more we try to control sleep with hacks or rigid routines, the more vigilant and stressed we become -- paradoxically making sleep harder," Pinkham said. Beauty over health Many sleepmaxxing posts focus on enhancing physical appearance rather than improving health, reflecting an overlap with "looksmaxxing" –- another online trend that encourages unproven and sometimes dangerous techniques to boost sexual appeal. Some sleepmaxxing influencers have sought to profit from the trend's growing popularity, promoting products such as mouth tapes, sleep-enhancing drink powders, and "sleepmax gummies" containing melatonin. That may be in violation of legal norms in some countries like Britain, where melatonin is available only as a prescription drug. The American Academy of Sleep Medicine has recommended against using melatonin to treat insomnia in adults, citing inconsistent medical evidence regarding its effectiveness. Some medical experts also caution about the impact of the placebo effect on insomnia patients using sleep medication -- when people report real improvement after taking a fake or nonexistent treatment because of their beliefs. "Many of these tips come from non-experts and aren't grounded in clinical evidence," said Pinkham.
Bangkok Post
04-08-2025
- Bangkok Post
Hong Kong records first imported case of chikungunya fever since 2019
Hong Kong has recorded its first imported case of chikungunya fever since 2019, involving a boy who returned from the mainland Chinese city of Foshan which is facing an outbreak of the mosquito-borne disease, the South China Morning Post has learned. A source confirmed the imported case of the chikungunya infection on Saturday, weeks after a surge in cases of the disease was identified in Guangdong. About 6,100 cases have been recorded in the province so far, with about 90% of patients concentrated in Foshan's Shunde district. The boy had been staying in Shunde for almost two weeks before returning to Hong Kong, according to a source. Infectious disease expert Yuen Kwok-yung said the 12-year-old boy travelled to Foshan for 14 days and developed a fever soon after returning to Hong Kong. He also had a rash and joint pain, and was admitted to United Christian Hospital in Kwun Tung, Yuen said. The boy's blood tested positive at the Centre for Health Protection, Yuen said, adding the patient had been transferred to Princess Margaret Hospital in Lai Chi Kok for mild conditions. "Everyone who comes back with any fever, joint pain or rash should be tested so that anti-mosquito work can be started around their homes and workplaces," he said. "All cargo from endemic areas should be inspected and anti-mosquito work done at cargo areas." Yuen said implementing proper anti-mosquito measures at cargo places and patients' residences or workplaces could prevent the virus from gaining a foothold in the city, adding that the efforts required the cooperation of residents and authorities. Health authorities are expected to announce more details later on Saturday. In Macau, six imported cases of chikungunya fever had been recorded since mid-July, four of which involved travel to Foshan during the incubation periods. Chinese Vice-Premier Liu Guozhong visited the southern city of Foshan in Guangdong province, urging residents to "strictly implement port health quarantine measures", according to state news agency Xinhua on Friday. During his trip to Guangdong, Liu told authorities to "improve prevention and control measures", "effectively eliminate mosquitoes" and halt the disease's "spread channels". Chikungunya fever is spread by Aedes albopictus mosquito bites, with cases typically developing fever and joint pain that can last for a long period. Other potential symptoms include muscle pain, nausea and rashes. It shares similar symptoms of dengue fever, another mosquito-borne disease, with one marked difference being that patients with the former often developed joint pain. Infectious disease expert Yuen warned earlier that any potential outbreak in the city could be on a large scale, due to weak immunity levels among the population. "After being infected, some people mistakenly believe they'll feel better in a few days, but that's not the case. The joint inflammation and swelling can persist for more than three months in about 40 per cent of patients," he said last week. Hong Kong last recorded cases of chikungunya fever in 2019, with the tally reaching 11 patients. The city also reported two cases in 2018, one in 2017 and eight in 2016. All cases between 2016 and 2019 were imported. The World Health Organization earlier issued an urgent call for action against chikungunya fever as the virus had been affecting other parts of the world, including Reunion Island, Madagascar, Kenya and India. Europe has also seen a growing number of imported cases and some local transmission. The word "chikungunya" comes from the east African language Kimakonde and means "to become contorted". It has been used to describe the stooped appearance of infected patients suffering from joint pain. The virus was first identified in 1952 in Tanzania. It then spread to other sub-Saharan countries and Southeast Asia. It has been reported in more than 110 countries, according to the WHO.
Bangkok Post
19-07-2025
- Bangkok Post
Chemotherapy can speed up cancer spread: study
HONG KONG — A team of Chinese scientists has found that the spread of cancer from original tumour sites to distant organs can be caused by chemotherapy triggering the awakening of dormant cancer cells. Their findings shed light on why breast cancer patients can experience cancer metastasis in organs like the lungs despite successful treatment of their primary tumours. The team also found that the use of specific drugs in combination with chemotherapy could be used to inhibit this process in mice, and a clinical trial is already under way in breast cancer patients. "We demonstrate that chemotherapeutic drugs, including doxorubicin and cisplatin, enhance proliferation and lung metastasis of dormant breast cancer cells," the team wrote in a paper published in the peer-reviewed journal Cancer Cell on July 3. "This study provides direct evidence of dormancy awakening and reveals a mechanism underlying [the] detrimental effect of chemotherapy on metastasis, highlighting potential strategies to improve cancer treatment." Researchers in the United States previously found that high doses of radiation therapy to treat cancer could paradoxically lead to the growth of metastatic tumours. Many patients who undergo chemotherapy to treat primary tumours, the original tumour site in the body where cancer cells first start to develop, can have cancer relapses in other organs even after complete primary tumour regression. This has led to research into whether chemotherapy can have a similar paradoxical effect, in which it both treats primary tumours and triggers cancer metastasis. "It is postulated that the reactivation, or awakening, of dormant disseminated tumour cells (DTCs) in distant organs results in metastatic relapse after the asymptomatic period," the team said. Studies have shown that disseminated cancer cells, which travel from primary tumours to sites in the body, can be found even during the early stages of primary cancer formation, according to a news release by the Chinese Academy of Sciences (CAS). These cells can stay in a dormant state for years, during which they do not grow and multiply, allowing them to evade chemotherapy. Researchers have previously identified molecular mechanisms that regulate metastatic relapse and disseminated cancer cell dormancy. However, it has not been clear whether metastasis results from the reactivation of dormant cells or the growth of rare, non-dormant disseminated cells. "Understanding the exogenous causes of DTC awakening will help disease management of cancer survivors, offering opportunities to prevent and interrupt metastatic relapse after initial therapies," the researchers said in their paper. To study this, the team led by Hu Guohong, a professor at CAS' Shanghai Institute of Nutrition and Health, along with researchers from Fudan University and Qilu Hospital of Shandong University, developed a cancer cell dormancy tracing approach. The team confirmed that chemotherapy-induced reactivation of dormant cells from breast cancer could lead to metastatic relapse in the lungs of mice. Their findings demonstrated that the "awakening of dormant DTCs, but not accumulation of pre-existing proliferative DTCs, is responsible for metastases induced by chemotherapy". Chemotherapy induces senescence - an accelerated state of ageing in which cells stop multiplying and release inflammation-causing chemicals - in specialised connective tissue called fibroblasts. The team found that senescent fibroblasts release proteins that cause immune cells called neutrophils to form weblike formations, called neutrophil extracellular traps, which change the environment in the lung into one that helps dormant cancer cells restart their growth. The remodelling of the extracellular matrix, a complex network of molecules that support and surround cells, also degrades tumour-suppressing factors. "We explored if chemotherapy-induced senescent fibroblasts could be a therapeutic target to improve the effect of chemotherapy on metastasis inhibition," the team said. The researchers discovered that combining senolytic drugs, which eliminate senescent cells, with the chemotherapy drug doxorubicin reduced senescent fibroblasts in the lungs of mice. "Since the senolytics have shown acceptable safety profiles and benefits in clinics, this could be a promising strategy and warrant further clinical investigation," they said. The team said that, based on these study results, a phase II clinical trial was under way to explore the safety of combining the senolytic drugs dasatinib and quercetin with chemotherapy to treat triple-negative breast cancer. Triple-negative breast cancer is an invasive and aggressive form of the disease that cannot be treated with the usual hormone therapy used to help treat such cancers.
